Abstract
The pathogenesis of Alzheimer’s disease (AD) has been suggested to be related with the aggregation of amyloid β (Aβ) peptides. Metal ions (e.g. Cu, Fe, and Zn) are supposed to induce the aggregation of Aβ. Recent development of bifunctional molecules that are capable of interacting with Aβ and chelating biometal ions provides promising therapeutics to AD. However, the molecular mechanism for how Aβ, metal ions, and bifunctional molecules interact with each other is still elusive. In this study, the binding mode of Zn2+-bound Aβ with bifunctional molecules was investigated by the combination of conformational sampling of full-length Aβ peptides using replica exchange molecular dynamics simulations (REMD) and conformational selection using molecular docking and classical MD simulations. We demonstrate that Zn2+-bound Aβ(1–40) and Aβ(1–42) exhibit different conformational ensemble. Both Aβ peptides can adopt various conformations to recognize typical bifunctional molecules with different binding affinities. The bifunctional molecules exhibit their dual functions by first preferentially interfering with hydrophobic residues 17–21 and/or 30–35 of Zn2+-bound Aβ. Additional interactions with residues surrounding Zn2+ could possibly disrupt interactions between Zn2+ and Aβ, which then facilitate these small molecules to chelate Zn2+. The binding free energy calculations further demonstrate that the association of Aβ with bifunctional molecules is driven by enthalpy. Our results provide a feasible approach to understand the recognition mechanism of disordered proteins with small molecules, which could be helpful to the design of novel AD drugs.









Similar content being viewed by others
Abbreviations
- AD:
-
Alzheimer’s disease
- Aβ:
-
Amyloid-β
- REMD:
-
Replica exchange molecular dynamics
- HBX:
-
2-(2-Hydroxylphenyl)benzoxazole
- MPY′:
-
4-(5-Hydoxylimidazo[1,2-a]pyridin-2-yl)-N,N-dimethylaniline
- L2B:
-
N1,N1-dimethyl-N4-(pyridin-2-ylmethyl)benzene-1,4-diamine
- EDTA:
-
Ethylenediaminetetraacetic acid
- CQ:
-
Clioquinol, 5-chloro-7-iodo-8-hydroxyquinoline
- PBT2:
-
8-Hydroxyquinoline derivative
References
Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 297:353–356
Jakob-Roetne R, Jacobsen H (2009) Alzheimer’s disease: from pathology to therapeutic approaches. Angew Chem Int Ed 48:3030–3059
Karran E, Mercken M, De Strooper B (2011) The amyloid cascade hypothesis for Alzheimer’s disease: an appraisal for the development of therapeutics. Nat Rev Drug Discov 10:698–712
Straub JE, Thirumalai D (2011) Toward a molecular theory of early and late events in monomer to amyloid fibril formation. Ann Rev Phys Chem 62:437–463
Perry G, Cash AD, Srinivas R, Smith MA (2002) Metals and oxidative homeostasis in Alzheimer’s disease. Drug Dev Res 56:293–299
Bush AI (2003) The metallobiology of Alzheimer’s disease. Trends Neurosci 26:207–214
Maynard CJ, Bush AI, Masters CL, Cappai R, Li QX (2005) Metals and amyloid-beta in Alzheimer’s disease. Int J Exp Pathol 86:147–159
Shcherbatykh I, Carpenter DO (2007) The role of metals in the etiology of Alzheimer’s disease. J Alzheimers Dis 11:191–205
Bush AI, Tanzi RE (2008) Therapeutics for Alzheimer’s disease based on the metal hypothesis. Neurotherapeutics 5:421–432
Chiang PK, Lam MA, Luo Y (2008) The many faces of amyloid β in Alzheimer’s disease. Curr Mol Med 8:580–584
Miura T, Suzuki K, Kohata N, Takeuchi H (2000) Metal binding modes of Alzheimer’s amyloid β-peptide in insoluble aggregates and soluble complexes. Biochemistry 39:7024–7031
Kozin SA, Zirah S, Rebuffat S, Hoa GH, Debey P (2001) Zinc binding to Alzheimer’s Aβ(1–16) peptide results in stable soluble complex. Biochem Biophys Res Commun 285:959–964
Minicozzi V, Stellato F, Comai M, Dalla Serra M, Potrich C, Meyer-Klaucke W, Morante S (2008) Identifying the minimal copper- and zinc-binding site sequence in amyloid-β peptides. J Biol Chem 283:10784–10792
Faller P, Hureau C (2009) Bioinorganic chemistry of copper and zinc ions coordinated to amyloid-β peptide. Dalton Trans 21:1080–1094
Faller P (2009) Copper and zinc binding to amyloid-β: coordination dynamics aggregation reactivity and metal-ion transfer. ChemBioChem 10:2837–2845
Tõugu V, Tiiman A, Palumaa P (2011) Interactions of Zn(II) and Cu(II) ions with Alzheimer’s amyloid-β peptide Metal ion binding contribution to fibrillization and toxicity. Metallomics 3:250–261
Watt NT, Whitehouse IJ, Hooper NM (2011) The role of zinc in Alzheimer’s disease. Int J Alzheimers Dis 2011:971021–971030
Rezaei-Ghaleh N, Giller K, Becker S, Zweckstetter M (2011) Effect of zinc binding on β-amyloid structure and dynamics: implications for Aβ aggregation. Biophys J 101:1202–1211
Zirah S, Kozin SA, Mazur AK, Blond A, Cheminant M, Ségalas-Milazzo I, Debey P, Rebuffat S (2006) Structural changes of region 1–16 of the Alzheimer disease amyloid β-peptide upon zinc binding and in vitro aging. J Biol Chem 281:2151–2161
Tsvetkov PO, Kulikova AA, Golovin AV, Tkachev YV, Archakov AI, Kozin SA, Makarov AA (2010) Minimal Zn2+ binding site of amyloid-β. Biophys J 99:L84–L86
Mekmouche Y, Coppel Y, Hochgräfe K, Guilloreau L, Tallmard C, Mazarguil H, Faller P (2005) Characterization of the ZnII binding to the peptide amyloid-β1–16 linked to Alzheimer’s disease. ChemBioChem 6:1663–1671
Gaggelli E, Janicka-Klos A, Jankowska E, Kozlowski H, Migliorini C, Molteni E, Valensin D, Valensin G, Wieczerzak E (2008) NMR studies of the Zn2 + interactions with rat and human β-amyloid (1–28) peptides in water-micelle environment. J Phys Chem B 112:100–109
Furlan S, La Penna G (2009) Modeling of the Zn2 + binding in the 1–16 region of the amyloid β peptide involved in Alzheimer’s disease. Phys Chem Chem Phys 11:6468–6481
Karr JW, Kaupp LJ, Szalai VA (2004) Amyloid-β binds Cu2+ in a mononuclear metal ion binding site. J Am Chem Soc 126:13534–13538
Kowalik-Jankowska T, Ruta M, Wisniewska K, Lankiewicz L (2003) Coordination abilities of the 1–16 and 1–28 fragments of β-amyloid peptide towards copper(II) ions: a combined potentiometric and spectroscopic study. J Inorg Biochem 95:270–282
Ma QF, Hu J, Wu WH, Liu HD, Du JT, Fu Y, Wu YW, Lei P, Zhao YF, Li YM (2006) Characterization of copper binding to the peptide amyloid-β(1–16) associated with Alzheimer’s disease. Biopolymers 83:20–31
Baruch-Suchodolsky R, Fischer B (2008) Soluble amyloid β1–28-copper(I)/copper(II)/iron(II) complexes are potent antioxidants in cell-free systems. Biochemistry 47:7796–7806
Gaggelli E, Grzonka Z, Kozlowski H, Migliorini C, Molteni E, Valensin D, Valensin G (2008) Structural features of the Cu(II) complex with the rat Aβ(1-28) fragment. Chem Commnu 341–343
Shin BK, Saxena S (2008) Direct evidence that all three histidine residues coordinate to Cu(II) in amyloid-β1–16. Biochemistry 47:9117–9123
Pedersen JT, Teilum K, Heegaard NHH, Østergaard J, Adolph HW, Hemmingsen L (2011) Rapid formation of a preoligomeric peptide-metal-peptide complex following copper(II) binding to Amyloid β peptides. Angew Chem Int Ed 50:2532–2535
Miller Y, Ma B, Nussinov R (2010) Polymorphism in Alzheimer Aβ amyloid organization reflects conformational selection in a rugged energy landscape. Chem Rev 110:4820–4838
Colletier JP, Laganowsky A, Landau M, Zhao M, Soriaga AB, Goldschmidt L, Flot D, Cascio D, Sawaya MR, Eisenberg D (2011) Molecular basis for amyloid-β polymorphism. Proc Natl Acad Sci USA 108:16938–16943
Yu X, Zheng J (2011) Polymorphic structures of Alzheimer’s β-amyloid globulomers. PLoS One 6:e20575
Miller Y, Ma B, Nussinov R (2010) Zinc ions promote Alzheimer Aβ aggregation via population shift of polymorphic states. Proc Natl Acad Sci USA 107:9490–9495
Parthasarathy S, Long F, Miller Y, Xiao Y, McElheny D, Thurber K, Ma B, Nussinov R, Ishii Y (2011) Molecular-level examination of Cu2+ binding structure for amyloid fibrils of 40-residue Alzheimer’s β by solid-state NMR spectroscopy. J Am Chem Soc 133:3390–3400
Ricchelli F, Drago D, Filippi B, Tognon G, Zatta P (2005) Aluminum-triggered structural modifications and aggregation of β-amyloids. Cell Mol Life Sci 62:1724–1733
Miller Y, Ma B, Nussinov R (2012) Metal binding sites in amyloid oligomers: Complexes and mechanisms. Coord Chem Rev. doi:10.1016/j.ccr.2011.12.022
Cohen T, Frydman-Marom A, Rechter M, Gazit E (2006) Inhibition of amyloid fibril formation and cytotoxicity by hydroxyindole derivatives. Biochemistry 45:4727–4735
Yadav A, Sonker M (2009) Perspectives in designing anti aggregation agents as Alzheimer disease drugs. Eur J Med Chem 44:3866–3873
Kim S, Chang WE, Kumar R, Klimov DK (2011) Naproxen interferes with the assembly of Aβ oligomers implicated in Alzheimer’s disease. Biophys J 100:2024–2032
Schütz AK, Soragni A, Hornemann S, Aguzzi A, Ernst M, Böckmann A, Meier BH (2011) The amyloid-Congo red interface at atomic resolution. Angew Chem Int Ed 50:5956–5960
Sood A, Abid M, Sauer C, Hailemichael S, Foster M, Török B, Török M (2011) Disassembly of preformed amyloid beta fibrils by small organofluorine molecules. Bioorg Med Chem Lett 21:2044–2047
Shiri S, Michal L, Anat F, Yaniv A, Roni S, Ludmila B, Ehud G, Hanoch S (2011) Quantitative structure–activity relationship analysis of β-amyloid aggregation inhibitors. J Comput Aided Mol Des 25:135–144
Viet MH, Ngo ST, Lam NS, Li MS (2011) Inhibition of aggregation of amyloid peptides by beta-sheet breaker peptides and their binding affinity. J Phys Chem B 115:7433–7446
Urbanc B, Betnel M, Cruz L, Li H, Fradinger EA, Monien BH, Bitan G (2011) Structural basis for Aβ 1–42 toxicity inhibition by Aβ C-terminal fragments: discrete molecular dynamics study. J Mol Biol 410:316–328
Yoo SI, Yang M, Brender JR, Subramanian V, Sun K, Joo NE, Jeong SH, Ramamoorthy A, Kotov NA (2011) Inhibition of amyloid peptide fibrillation by inorganic nanoparticles: functional similarities with proteins. Angew Chem Int Ed 50:5110–5115
Finefrock AE, Bush AI, Doraiswamy PM (2003) Current status of metals as therapeutic targets in Alzheimer’s disease. J Am Geriatr Soc 51:1143–1148
Bush AI (2008) Drug development based on the metals hypothesis of Alzheimer’s disease. J Alzheimers Dis 15:223–240
Hider RC, Ma YM, Molina-Holgado F, Gaeta A, Roy S (2008) Iron chelation as a potential therapy for neurodegenerative disease. Biochem Soc Trans 36:1304–1308
Perez LR, Franz KJ (2010) Minding metals: tailoring multifunctional chelating agents for neurodegenerative disease. Dalton Trans 39:2177–2187
Rodríguez-Rodríguez C, de Groot NS, Rimola A, Álvarez-Larena A, Lloveras V, Vidal-Gancedo J, Ventura S, Vendrell J, Sodupe M, González-Duarte P (2009) Design selection and characterization of thioflavin-based intercalation compounds with metal chelating properties for application in Alzheimer’s disease. J Am Chem Soc 131:1436–1451
Mancino AM, Hindo SS, Kochi A, Lim MH (2009) Effects of clioquinol on metal-triggered amyloid-β aggregation revisited. Inorg Chem 48:9596–9598
Braymer JJ, Detoma AS, Choi JS, Ko KS, Lim MH (2011) Recent development of bifunctional small molecules to study metal-amyloid-β species in Alzheimer’s disease. Int J Alzheimers Dis 2011:623051–623060
Hindo SS, Mancino AM, Braymer JJ, Liu Y, Vivekanandan S, Ramamoorthy A, Lim MH (2009) Small molecule modulators of copper-induced Abeta aggregation. J Am Chem Soc 131:16663–16665
Choi JS, Braymer JJ, Nanga RPR, Ramamoorthy A, Lim MH (2010) Design of small molecules that target metal-Aβ species and regulate metal-induced Aβ aggregation and neurotoxicity. Proc Natl Acad Sci USA 107:21990–21995
Wu WH, Lei P, Liu Q, Hu J, Gunn AP, Chen MS, Rui YF, Su XY, Xie ZP, Zhao YF, Bush AI, Li YM (2008) Sequestration of copper from β-amyloid promotes selective lysis by cyclen-hybrid cleavage agents. J Biol Chem 283:31657–31664
Jensen M, Canning A, Chiha S, Bouquerel P, Pedersen JT, Østergaard J, Cuvillier O, Sasaki I, Hureau C, Faller P (2012) Inhibition of Cu-amyloid-β by using bifunctional peptides with β-sheet breaker and chelator moieties. Chem Eur J 18:4836–4839
Dedeoglu A, Cormier K, Payton S, Tseitlin KA, Kremsky JN, Lai L, Li XH, Moir RD, Tanzi RE, Bush AI, Kowall NW, Rogers JT, Huang XD (2004) Preliminary studies of a novel bifunctional metal chelator targeting Alzheimer’s amyloidogenesis. Expl Gerontol 39:1641–1649
Boehr DD, Nussinov R, Wright PE (2009) The role of dynamic conformational ensembles in biomolecular recognition. Nat Chem Biol 5:789–796
Sugita Y, Okamoto Y (1999) Replica-exchange molecular dynamics method for protein folding. Chem Phys Lett 314:141–151
Mitsutake A, Sugita Y, Okamoto Y (2001) Generalized-ensemble algorithms for molecular simulations of biopolymers. Biopolymers 60:96–123
Morris GM, Goodsell DS, Halliday RS, Huey R, Hart WE, Belew RK, Olson AJ (1998) Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J Comput Chem 19:1639–1662
Huey R, Morris GM, Olson AJ, Goodsell DS (2007) A semiempirical free energy force field with charge-based desolvation. J Comput Chem 28:1145–1152
Kollman PA, Massova I, Reyes C, Kuhn B, Huo SH, Chong L, Lee M, Lee T, Duan Y, Wang W, Donini O, Cieplak P, Srinivasan J, Case DA, Cheatham TE (2000) Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. Acc Chem Res 33:889–897
Hoops SC, Anderson KW, Merz KM (1991) Force-field design for metalloproteins. J Am Chem Soc 113:8262–8270
Peters MB, Yang Y, Wang B, Füsti-Molnár L, Weaver MN, Merz KM Jr (2010) Structural survey of zinc containing proteins and the development of the zinc AMBER force field (ZAFF). J Chem Theory Comput 6:2935–2947
Lin F, Wang RX (2010) Systematic derivation of AMBER force field parameters applicable to zinc-containing systems. J Chem Theory Comput 6:1852–1870
Wang JM, Cieplak P, Kollman PA (2000) How well does a restrained electrostatic potential (RESP) model perform in calculating conformational energies of organic and biological molecules? J Comput Chem 21:1049–1074
Lührs T, Ritter C, Adrian M, Riek-Loher D, Bohrmann B, Döeli H, Schubert D, Riek R (2005) 3D structure of Alzheimer’s amyloid-β(1–42) fibrils. Proc Natl Acad Sci USA 102:17342–17347
Li WF, Zhang J, Su Y, Wang J, Qin M, Wang W (2007) Effects of zinc binding on the conformational distribution of the amyloid-β peptide based on molecular dynamics simulations. J Phys Chem B 111:13814–13821
Miller Y, Ma BY, Nussinov R (2011) The unique Alzheimer’s β-amyloid triangular fibril has a cavity along the fibril axis under physiological conditions. J Am Chem Soc 133:2742–2748
Yang MF, Teplow DB (2008) Amyloid β-protein monomer folding: free-energy surfaces reveal alloform-specific differences. J Mol Biol 384:450–464
Sgourakis NG, Merced-Serrano M, Boutsidis C, Drineas P, Du ZM, Wang CY, Garcia AE (2011) Atomic-level characterization of the ensemble of the Aβ(1–42) Monomer in water using unbiased molecular dynamics simulations and spectral algorithms. J Mol Biol 405:570–583
Sgourakis NG, Yan YL, McCallum SA, Wang CY, Garcia AE (2007) The Alzheimer’s peptides Aβ 40 and 42 adopt distinct conformations in water: a combined MD/NMR study. J Mol Biol 368:1448–1457
Jang S, Shin S (2006) Amyloid β-peptide oligomerization in silico: dimer and trimer. J Phys Chem B 110:1955–1958
Case DA, Darden TA, Cheatham III TE, Simmerling CL, Wang J, Duke RE, Luo R, Walker RC, Zhang W, Merz KM, Roberts BP, Wang B, Hayik S, Roitberg A, Seabra G, Kolossvai I, Wong KF, Paesani F, Vanicek J, Liu J, Wu X, Brozell SR, Steinbrecher T, Gohlke H, Cai Q, Ye X, Wang J, Hsieh MJ, Cui G, Roe DR, Mathews DH, Seetin MG, Sagui C, Babin V, Luchko T, Gusarov S, Kovalenko A, Kollman PA (2010) AMBER 11; University of California San Francisco
Hornak V, Abel R, Okur A, Strockbine B, Roitberg A, Simmerling C (2006) Comparison of multiple amber force fields and development of improved protein backbone parameters. Proteins 65:712–725
Onufriev A, Bashford D, Case DA (2004) Exploring protein native states and large-scale conformational changes with a modified generalized born model. Proteins 55:383–394
Daura X, Gademann K, Jaun B, Seebach D, van Gunsteren WF, Mark AE (1999) Peptide folding: when simulation meets experiment. Angew Chem Int Ed 38:236–240
Wang JM, Wang W, Kollman PA, Case DA (2006) Automatic atom type and bond type perception in molecular mechanical calculations. J Mol Graph Model 25:247–260
Wang JM, Wolf RM, Caldwell JW, Kollman PA, Case DA (2004) Development and testing of a general amber force field. J Comput Chem 25:1157–1174
Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML (1983) Comparison of simple potential functions for simulating liquid water. J Chem Phys 79:926–935
Darden T, York D, Pedersen L (1993) Particle mesh Ewald - an NLog(N) method for Ewald sums in large systems. J Chem Phys 98:10089–10092
Hess B, Bekker H, Berendsen HJC, Fraaije JGEM (1997) LINCS: a linear constraint solver for molecular simulations. J Comput Chem 18:1463–1472
Khandogin J, Brooks CL (2007) Linking folding with aggregation in Alzheimer’s β-amyloid peptides. Proc Natl Acad Sci USA 104:16880–16885
Yan YL, Wang CY (2006) Aβ 42 is more rigid than Aβ 40 at the C terminus: implications for Aβ aggregation and toxicity. J Mol Biol 364:853–862
Hou LM, Shao HY, Zhang YB, Li H, Menon NK, Neuhaus EB, Brewer JM, Byeon IJL, Ray DG, Vitek MP, Iwashita T, Makula RA, Przybyla AB, Zagorski MG (2004) Solution NMR studies of the Aβ(1–40) and Aβ(1–42) peptides establish that the met35 oxidation state affects the mechanism of amyloid formation. J Am Chem Soc 126:1992–2005
Liu RT, McAllister C, Lyubchenko Y, Sierks MR (2004) Residues 17–20 and 30–35 of beta-amyloid play critical roles in aggregation. J Neurosci Res 75:162–171
Baumketner A, Shea JE (2007) The structure of the Alzheimer amyloid β 10–35 peptide probed through replica-exchange molecular dynamics simulations in explicit solvent. J Mol Biol 366:275–285
Riek R, Güntert P, Döbeli H, Wipf B, Wüthrich K (2001) NMR studies in aqueous solution fail to identify significant conformational differences between the monomeric forms of two Alzheimer peptides with widely different plaque-competence Aβ(1–40)ox and Aβ(1–42)ox. Eur J Biochem 268:5930–5936
Yu L, Edalji R, Harlan JE, Holzman TF, Lopez AP, Labkovsky B, Hillen H, Barghorn S, Ebert U, Richardson PL, Miesbauer L, Solomon L, Bartley D, Walter K, Johnson RW, Hajduk PJ, Olejniczak ET (2009) Structural characterization of a soluble amyloid β-peptide oligomer. Biochemistry 48:1870–1877
Bitan G, Kirkitadze MD, Lomakin A, Vollers SS, Benedek GB, Teplow DB (2003) Amyloid β-protein (Aβ) assembly: Aβ40 and Aβ42 oligomerize through distinct pathways. Proc Natl Acad Sci USA 100:330–335
Schmidt M, Sachse C, Richter W, Xu C, Fandrich M, Grigorieff N (2009) Comparison of Alzheimer Aβ(1–40) and Aβ(1–42) amyloid fibrils reveals similar protofilament structures. Proc Natl Acad Sci USA 106:19813–19818
Sánchez L, Madurga S, Pukala T, Vilaseca M, López-Iglesias C, Robinson CV, Giralt E, Carulla N (2011) Aβ40 and Aβ42 amyloid fibrils exhibit distinct molecular recycling properties. J Am Chem Soc 133:6505–6508
Alonso H, Bliznyuk AA, Gready JE (2006) Combining docking and molecular dynamic simulations in drug design. Med Res Rev 26:531–568
Li J, Liu R, Lam KS, Jin LW, Duan Y (2011) Alzheimer’s disease drug candidates stabilize A-β protein native structure by interacting with the hydrophobic core. Biophys J 100:1076–1082
Acknowledgments
We are grateful to Dr. Orkid Coskuner-Weber (The University of Texas at San Antonio, USA) for critical comments of this research. Computations were performed on the clusters at the High-Performance Computing Center of Dalian University of Technology. This work is supported by the Major State Basic Research Development Program (Grant No. 200900376). Dr. Xu and Dr. Bao thanks financial support from the Fundamental Research Funds for the Central Universities (grant No. DUT12LK38 and DUT11SM01).
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
10822_2012_9588_MOESM1_ESM.doc
Supplementary Material The computational details of RESP charges for the model structures, as well as figures mentioned in the main text are provided in the Supplementary Material. (DOC 10712 kb)
Rights and permissions
About this article
Cite this article
Xu, L., Gao, K., Bao, C. et al. Combining conformational sampling and selection to identify the binding mode of zinc-bound amyloid peptides with bifunctional molecules. J Comput Aided Mol Des 26, 963–976 (2012). https://doi.org/10.1007/s10822-012-9588-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10822-012-9588-4